ahlam1399
07-18-2016, 07:43 PM
Brainstorm?s cell therapy succeeds in ALS mid-stage study
(Reuters) - Brainstorm Cell Therapeutics Inc said its experimental cell therapy was safe and well tolerated in patients with amyotrophic lateral sclerosis (ALS), a progressive neurological disorder, in a mid-stage study.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=6pbnfRt1cfM:cc3SHrCUS9A:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=6pbnfRt1cfM:cc3SHrCUS9A:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=6pbnfRt1cfM:cc3SHrCUS9A:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=6pbnfRt1cfM:cc3SHrCUS9A:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=6pbnfRt1cfM:cc3SHrCUS9A:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/6pbnfRt1cfM
(Reuters) - Brainstorm Cell Therapeutics Inc said its experimental cell therapy was safe and well tolerated in patients with amyotrophic lateral sclerosis (ALS), a progressive neurological disorder, in a mid-stage study.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=6pbnfRt1cfM:cc3SHrCUS9A:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=6pbnfRt1cfM:cc3SHrCUS9A:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=6pbnfRt1cfM:cc3SHrCUS9A:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=6pbnfRt1cfM:cc3SHrCUS9A:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=6pbnfRt1cfM:cc3SHrCUS9A:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/6pbnfRt1cfM